Abstract
Breast cancer will increasingly affect the lives of older women, especially in developed countries. In the last three decades, women of all age groups have experienced the benefits of a lowering mortality rate though earlier diagnosis and effective treatment. These benefits have been counteracted by the rising incidence, resulting from higher levels of exposure to risk factors and possibly also from the increased detection of occult, non lethal invasive breast cancers. At the same time, demographics are characterized by a large increase in the elderly population, which will become even more pronounced during the next decades. The most remarkable increase in the absolute number of newly diagnosed breast cancer patients and long-term survivors (at risk for recurrent disease or second breast cancers) will thus exhibit among the higher age groups, the prevalence doubling from 3.5% in 2000 to 7% in 2015 in the Netherlands (Poll-Franse et al., SignaleringscommissieKanker. Kanker in Nederland. Trends, prognoses en implicaties voor zorgvraag. KWF Kankerbestrijding, Amsterdam, 2004). Being confronted with these rising numbers of patients or anticipating them, many doctors and clinical researchers have taken a special interest in the study of breast cancer in older women (Bouchardy et al., J Clin Oncol 25(14):1858–1869, 2007), as is reflected by the increasing number of papers with a special focus on this group.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Annual report 2005 in Dutch.‘s (2006) Hertogenbosch: Stichting Bevolkingsonderzoek Borstkanker Zuid.
Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008;26(20):3324–30.
Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881–10882 trial. J Clin Oncol. 2007;25(22):3259–65.
Bijker N, Peterse JL, Fentiman IS, Julien JP, Hart AA, Avril A, et al. Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS. Br J Cancer. 2002;87(6):615–20.
Bouchardy C, Rapiti E, Blagojevic S, Vlastos AT, Vlastos G. Older female cancer patients: importance, causes, and consequences of undertreatment. J Clin Oncol. 2007;25(14):1858–69.
Clarke M, Coates AS, Darby SC, Davies C, Gelber RD, Godwin J, et al. Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet. 2008;371(9606):29–40.
Coebergh JW, Crommelin MA, Kluck HM, van Beek M, van der Horst F, Verhagen-Teulings MT. Breast cancer in southeast North Brabant and in North Limburg; trends in incidence and earlier diagnosis in an unscreened female population, 1975–1986. Ned Tijdschr Geneeskd. 1990;134(15):760–5.
Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst. 2000;92(7):550–6.
Doyle JJ, Neugut AI, Jacobson JS, Wang J, McBride R, Grann A, et al. Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients. Int J Radiat Oncol Biol Phys. 2007;68(1):82–93.
Duijm LE, Groenewoud JH, Roumen RM, de Koning HJ, Plaisier ML, Fracheboud J. A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer. Breast Cancer Res Treat. 2007;106:113–9.
Duric V, Stockler M. Patients’ preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile. Lancet Oncol. 2001;2(11):691–7.
Eaker S, Dickman PW, Bergkvist L, Holmberg L. Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden. PLoS Med. 2006;3(3):e25.
Extermann M, Aapro M, Bernabei R, Cohen HJ, Droz JP, Lichtman S, et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005;55(3):241–52.
Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, Bondy ML. Breast cancer treatment guidelines in older women. J Clin Oncol. 2005;23(4):783–91.
Gorin SS, Heck JE, Cheng B, Smith SJ. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med. 2006;166(20):2244–52.
Hebert-Croteau N, Brisson J, Latreille J, Blanchette C, Deschenes L. Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer. 1999;85(5):1104–13.
Hillner BE, Mandelblatt J. Caring for older women with breast cancer: can observational research fill the clinical trial gap? J Natl Cancer Inst. 2006;98(10):660–1.
Holmberg L, Garmo H, Granstrand B, Ringberg A, Arnesson LG, Sandelin K, et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol. 2008;26(8):1247–52.
Jansen SJ, Otten W, Stiggelbout AM. Review of determinants of patients’ preferences for adjuvant therapy in cancer. J Clin Oncol. 2004;22(15):3181–90.
Kimmick GG, Peterson BL, Kornblith AB, Mandelblatt J, Johnson JL, Wheeler J, et al. Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001. J Clin Oncol. 2005;23(10):2201–7.
Louwman WJ, Vulto JC, Verhoeven RH, Nieuwenhuijzen GA, Coebergh JW, Voogd AC. Clinical epidemiology of breast cancer in the elderly. Eur J Cancer. 2007;43(15):2242–52.
Mandelblatt J. Treating breast cancer: the age old dilemma of old age. J Clin Oncol. 2006;24(27):4369–70.
Mandelblatt J, Kreling B, Figeuriedo M, Feng S. What is the impact of shared decision making on treatment and outcomes for older women with breast cancer? J Clin Oncol. 2006;24(30):4908–13.
Marinello R, Marenco D, Roglia D, Stasi MF, Ferrando A, Ceccarelli M, et al. Predictors of treatment failures during chemotherapy: A prospective study on 110 older cancer patients. Arch Gerontol Geriatr. 2008;48(2):222–6.
Molino A, Giovannini M, Auriemma A, Fiorio E, Mercanti A, Mandara M, et al. Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Crit Rev Oncol Hematol. 2006;59(3):226–33.
Mustacchi G, Cazzaniga ME, Pronzato P, De Matteis A, Di Costanzo F, Floriani I. Breast cancer in elderly women: a different reality? Results from the NORA study. Ann Oncol. 2007;18(6):991–6.
van de Poll-Franse LV, Coebergh JW, Houterman S, Mols, F, Alers JC, van den Berg FA, Haes,, Koning,, Leeuwen,, Schornagel,, Oost,, Soerjomataram,, Voogd,, & Vries (2004) SignaleringscommissieKanker. Kanker in Nederland. Trends, prognoses en implicaties voor zorgvraag. KWF Kankerbestrijding, Amsterdam.
Pollock AM, Vickers N. Why are a quarter of all cancer deaths in south-east England registered by death certificate only? Factors related to death certificate only registrations in the Thames Cancer Registry between 1987 and 1989. Br J Cancer. 1995;71(3):637–41.
Robinson D, Sankila R, Hakulinen T, Moller H. Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates. Eur J Cancer. 2007;43(5):909–13.
Siesling S, van de Poll-Franse LV, Jobsen JJ, Repelaer van Driel OJ, Voogd AC. Explanatory factors for variation in the use of breast conserving surgery and radiotherapy in the Netherlands, 1990–2001. Breast. 2007;16(6):606–14.
Siu LL. Clinical trials in the elderly—a concept comes of age. N Engl J Med. 2007;356(15):1575–6.
Smith BD, Gross CP, Smith GL, Galusha DH, Bekelman JE, Haffty BG. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst. 2006;98(10):681–90.
Sukel MP, van de Poll-Franse LV, Nieuwenhuijzen GA, Vreugdenhil G, Herings RM, Coebergh JW, et al. Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990–2006 in the southeastern Netherlands. Eur J Cancer. 2008;44(13):1846–54.
Vulto AJ, Lemmens VE, Louwman MW, Janssen-Heijnen ML, Poortmans PH, Lybeert ML, et al. The influence of age and co-morbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002. Cancer. 2006;106(12):2734–42.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Voogd, A.C., Louwman, M.J., Coebergh, J.W.W. (2019). Clinical Epidemiology and the Impact of Co-morbidity on Survival. In: Reed, M., Audisio, R. (eds) Management of Breast Cancer in Older Women. Springer, Cham. https://doi.org/10.1007/978-3-030-11875-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-11875-4_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11874-7
Online ISBN: 978-3-030-11875-4
eBook Packages: MedicineMedicine (R0)